Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Journal of the Korean Society for Therapeutic Radiology ; : 45-50, 1989.
Article in Korean | WPRIM | ID: wpr-75077

ABSTRACT

From Feb. 1985 to Feb. 1988, 76 patients with squamous cell carcinoma of the lung treated at the Department of Therapeutic Radiology in Kyungpook National University Hospital were available for the analysis of this study. All patients received radiation of 4000c0y-6600c0y with curative aim. The overall rate of complete response was 25.0% and partial response was 52.6%. The complete and partial regression of tumor was 14.3% in patients treated with dose below 5000 cGy and 84.1% in the group treated with dose above 5000 cGy (p<0.01). The complete response was seen only in the group of patients received radiation at least 6000 cGy. The patterns of failure were as follows. The rate of initial intrathoracic recurrence was 52.6% in patients with complete response. The overall rate of failure was 67.8%. Distant metastasis was found in 47.4% of patients. Bone, contralateral lung, and brain were common metastatic sites in decreasing order. All of the distant metastases and 80% of local recurrences were found within the first year after treatment.


Subject(s)
Humans , Brain , Carcinoma, Squamous Cell , Lung Neoplasms , Lung , Neoplasm Metastasis , Radiation Oncology , Radiotherapy , Recurrence
2.
Journal of the Korean Society for Therapeutic Radiology ; : 205-212, 1989.
Article in English | WPRIM | ID: wpr-96248

ABSTRACT

From July 1984 to September 1988, 27 patients with limited stage small cell lung cancer were treated with combined modality(combination chemotherapy Plus radiotherapy) at the Department of Therapeutic Radiology in Kyungpook National University Hospital. Of the 27 patients, 19(70%) achieved a complete response, 6(22%) a partial response, and 2(8%) no response. Female, performance status HO, serum enolase level below 30ng/ml, radiation dose over 4500 cGy, and 4 or more cycles of chemotherapy had a favorable effect on the rates of complete response, although there were no statistical differences according to the variables. Median survival time was 10 Months and overall 1- and 2-year survival rates were 40.7% and 12.2%, respectively. Complete response(p<0.05), performance status HO(p<0.05), 4 or more cycles of chemotherapy(p<0.05), and radiation dose over 4500 cGy had a significantly favorable effect on 2-year survival rate. Prophylactic cranial irradiation or sex had no effect on survival. The results of this study suggest that radiation treatment should be combined with combination chemotherapy in the therapeutic strategy of SCLC of limited stage.


Subject(s)
Female , Humans , Carcinoma, Small Cell , Combined Modality Therapy , Cranial Irradiation , Drug Therapy , Drug Therapy, Combination , Lung Neoplasms , Phosphopyruvate Hydratase , Radiation Oncology , Small Cell Lung Carcinoma , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL